{"id":1346,"date":"2016-02-29T14:17:43","date_gmt":"2016-02-29T13:17:43","guid":{"rendered":"https:\/\/ngm-cancer.com\/en\/?page_id=1346"},"modified":"2016-03-16T15:30:00","modified_gmt":"2016-03-16T14:30:00","slug":"service-invoicing","status":"publish","type":"page","link":"https:\/\/ngm-cancer.com\/en\/service-invoicing\/","title":{"rendered":"Service invoicing"},"content":{"rendered":"

[et_pb_section admin_label=”Sektion” global_module=”1255″ fullwidth=”on” specialty=”off” transparent_background=”off” allow_player_pause=”off” inner_shadow=”off” parallax=”off” parallax_method=”off” padding_mobile=”off” make_fullwidth=”off” use_custom_width=”off” width_unit=”on” make_equal=”off” use_custom_gutter=”off”][et_pb_fullwidth_image global_parent=”1255″ admin_label=”Volle Breite des Bildes” src=”https:\/\/ngm-cancer.com\/wp-content\/uploads\/2016\/02\/291_1920x400_iStock_000066163907_Double.jpg” show_in_lightbox=”off” url_new_window=”off” use_overlay=”off” animation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid” custom_css_main_element=”max-height:350px;”] [\/et_pb_fullwidth_image][\/et_pb_section][et_pb_section admin_label=”section”][et_pb_row admin_label=”row”][et_pb_column type=”2_3″][et_pb_text admin_label=”Text” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]<\/p>\n

Service invoicing<\/h1>\n

[\/et_pb_text][et_pb_text admin_label=”Text” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]<\/p>\n

The fundamental philosophy of the Network Genomic Medicine (NGM) is to conduct comprehensive diagnostics in any patient with a non-resectable lung tumor that clarifies all aspects of possible treatment decisions promptly and irrespective of the question of reimbursement. The participation of the attending physician and the patient in the integrated care is a prerequisite for this.<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″][et_pb_image admin_label=”Bild” src=”https:\/\/ngm-cancer.com\/wp-content\/uploads\/2015\/12\/csm_leistungsabrechnung_Fotolia_53105774_S_2a3cf3ea73.jpg” alt=”Netzwerk Genomische Medizin (NGM) Lungenkrebs” show_in_lightbox=”off” url_new_window=”off” use_overlay=”off” animation=”fade_in” sticky=”off” align=”left” force_fullwidth=”off” always_center_on_mobile=”on” use_border_color=”off” border_color=”#ffffff” border_style=”solid”] [\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row admin_label=”Zeile”][et_pb_column type=”4_4″][et_pb_text admin_label=”Text” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]<\/p>\n

The costs for the molecular pathological diagnosis and a second opinion are covered by the health insurer for patients of the AOK Rheinland \/ Hamburg as part of an integrated care contract (IV) since 01.04.2014.<\/p>\n

In 2016 more health insurance companies cover the full cost of molecular diagnostics and second opinion within the framework of the integrated care. In patients with other health insurers, the network center requests reimbursement for the individual case, so that all costs will be covered in accordance with the IV contract \/ standard fee.<\/p>\n

[\/et_pb_text][et_pb_text admin_label=”Last Update” global_module=”1340″ saved_tabs=”all” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid” module_class=”content-update”]<\/p>\n

Last update: 16. March 2016 , 15:30<\/span><\/em><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section admin_label=”section” global_module=”1336″ fullwidth=”off” transparent_background=”off” background_color=”#eeeeee” allow_player_pause=”off” inner_shadow=”off” parallax=”on” parallax_method=”on” padding_mobile=”off” make_fullwidth=”off” use_custom_width=”off” width_unit=”on” make_equal=”off” use_custom_gutter=”off” gutter_width=”3″ background_image=”https:\/\/ngm-cancer.com\/wp-content\/uploads\/2015\/12\/291_ngm_BG-t5.png”][et_pb_row global_parent=”1336″ admin_label=”row” make_fullwidth=”off” use_custom_width=”off” width_unit=”on” use_custom_gutter=”off” gutter_width=”3″ padding_mobile=”off” allow_player_pause=”off” parallax=”off” parallax_method=”on” make_equal=”on” parallax_1=”off” parallax_method_1=”off” background_color_1=”#ffffff” padding_top_1=”50px” padding_right_1=”32px” padding_bottom_1=”50px” padding_left_1=”32px” parallax_2=”off” parallax_method_2=”off” background_color_2=”#ffffff” padding_top_2=”50px” padding_right_2=”32px” padding_bottom_2=”50px” padding_left_2=”32px” parallax_3=”off” parallax_method_3=”off” background_color_3=”#ffffff” padding_top_3=”50px” padding_right_3=”32px” padding_bottom_3=”50px” padding_left_3=”32px” column_padding_mobile=”on” module_id=”pseudofooter-row”][et_pb_column type=”1_3″][et_pb_blurb global_parent=”1336″ admin_label=”Molekulare Diagnostik” title=”Molecular diagnostics” url_new_window=”off” animation=”off” background_layout=”light” text_orientation=”center” icon_placement=”top” font_icon=”%%103%%” use_icon=”on” use_circle=”off” use_circle_border=”off” icon_color=”#3b78aa” circle_color=”#81d742″ circle_border_color=”#2caaca” url=”\/?p=74\/” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid” header_line_height=”1.5em”] As the first group in Europe, the Network Genomic Medicine has offered a comprehensive analysis of tumor material since 2012. By means of a multiplex-test in combination with highly sensitive deep sequencing even rare gene mutations in the smallest tissue samples are detected reliably [\/et_pb_blurb][et_pb_divider global_parent=”1336″ admin_label=”Teiler” color=”#ffffff” show_divider=”off” divider_style=”solid” divider_position=”top” hide_on_mobile=”on” height=”2″] [\/et_pb_divider][et_pb_cta global_parent=”1336″ admin_label=”Diagnostik” button_url=”https:\/\/ngm-cancer.com\/en\/diagnostics\/” url_new_window=”off” button_text=”Diagnostics” use_background_color=”off” background_color=”#4d9acf” background_layout=”light” text_orientation=”center” use_border_color=”off” border_color=”#ffffff” border_style=”solid” custom_button=”off” button_text_size=”16″ button_border_radius=”0″ button_letter_spacing=”0″ button_use_icon=”default” button_icon_placement=”right” button_on_hover=”on” button_border_radius_hover=”0″ button_letter_spacing_hover=”0″] [\/et_pb_cta][\/et_pb_column][et_pb_column type=”1_3″][et_pb_blurb global_parent=”1336″ admin_label=”Second opinion” title=”Second opinion” url_new_window=”off” animation=”off” background_layout=”light” text_orientation=”center” icon_placement=”top” font_icon=”%%86%%” use_icon=”on” use_circle=”off” use_circle_border=”off” icon_color=”#3b78aa” circle_color=”#999999″ circle_border_color=”#2caaca” url=”\/?p=76\/” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid” header_line_height=”1.5em”] Do you have questions about your disease or your current therapy? Or maybe you would like to know if for you a personalized treatment approach or immunotherapy might be considered. Please feel free to contact us! [\/et_pb_blurb][et_pb_divider global_parent=”1336″ admin_label=”Teiler” color=”#ffffff” show_divider=”off” height=”53″ divider_style=”solid” divider_position=”top” hide_on_mobile=”on”] [\/et_pb_divider][et_pb_cta global_parent=”1336″ admin_label=”Zweitmeinung” button_url=”https:\/\/ngm-cancer.com\/en\/second-opinion-service\/” url_new_window=”off” button_text=”Second Opinion” use_background_color=”off” background_color=”#4d9acf” background_layout=”light” text_orientation=”center” use_border_color=”off” border_color=”#ffffff” border_style=”solid” custom_button=”off” button_text_size=”16″ button_border_radius=”0″ button_letter_spacing=”0″ button_use_icon=”default” button_icon_placement=”right” button_on_hover=”on” button_border_radius_hover=”0″ button_letter_spacing_hover=”0″] [\/et_pb_cta][\/et_pb_column][et_pb_column type=”1_3″][et_pb_blurb global_parent=”1336″ admin_label=”Clinical trials” title=”Clinical trials” url_new_window=”off” animation=”off” background_layout=”light” text_orientation=”center” icon_placement=”top” font_icon=”%%77%%” use_icon=”on” use_circle=”off” use_circle_border=”off” icon_color=”#3b78aa” circle_color=”#81d742″ circle_border_color=”#2caaca” url=”\/?p=76\/” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid” header_line_height=”1.5em”] At the Network Genomic Medicine we try to offer an appropriate clinical trial testing a new drug to all our patients who have a detected mutation, for which there has no drug been approved for treatment yet. For that we work closely together with the Lung Cancer Group Cologne. [\/et_pb_blurb][et_pb_divider global_parent=”1336″ admin_label=”Teiler” color=”#ffffff” show_divider=”off” height=”2″ divider_style=”solid” divider_position=”top” hide_on_mobile=”on”] [\/et_pb_divider][et_pb_cta global_parent=”1336″ admin_label=”Studien” button_url=”https:\/\/ngm-cancer.com\/en\/clinical-trials\/” url_new_window=”off” button_text=”Trials” use_background_color=”off” background_color=”#4d9acf” background_layout=”light” text_orientation=”center” use_border_color=”off” border_color=”#ffffff” border_style=”solid” custom_button=”off” button_text_size=”16″ button_border_radius=”0″ button_letter_spacing=”0″ button_use_icon=”default” button_icon_placement=”right” button_on_hover=”on” button_border_radius_hover=”0″ button_letter_spacing_hover=”0″] [\/et_pb_cta][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

Service invoicing The fundamental philosophy of the Network Genomic Medicine (NGM) is to conduct comprehensive diagnostics in any patient with a non-resectable lung tumor that clarifies all aspects of possible treatment decisions promptly and irrespective of the question of reimbursement. The participation of the attending physician and the patient in the integrated care is a […]<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":0,"menu_order":31,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"

Die grunds\u00e4tzliche Philosophie im Netzwerk Genomische Medizin (NGM) besteht darin, bei jedem Patienten mit einem nicht resektablen, b\u00f6sartigen Lungentumor eine umfassende Diagnostik durchzuf\u00fchren, die alle Aspekte m\u00f6glicher Therapieentscheidungen zeitnah und unabh\u00e4ngig von der Frage einer Kostenerstattung abkl\u00e4rt. Voraussetzung hierf\u00fcr ist eine Teilnahme des behandelnden Arztes und des Patienten an der Integrierten Versorgung<\/a>.<\/p>","_et_gb_content_width":""},"kontext":[],"_links":{"self":[{"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/pages\/1346"}],"collection":[{"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/comments?post=1346"}],"version-history":[{"count":1,"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/pages\/1346\/revisions"}],"predecessor-version":[{"id":2192,"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/pages\/1346\/revisions\/2192"}],"wp:attachment":[{"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/media?parent=1346"}],"wp:term":[{"taxonomy":"kontext","embeddable":true,"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/kontext?post=1346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}